Pfizer CEO says omicron vaccine will be ready in March Pfizer CEO Albert Bourla said the goal is to product a vaccine that is much better at preventing infection from omicron. Spencer Kimball CNBC

fizer CEO Albert Bourla said a vaccine that targets the omicron variant of Covid will be ready in March, and the company’s already begun manufacturing the doses.

“This vaccine will be ready in March,” Bourla told CNBC’s Squawk Box. “We (are) already starting manufacturing some of these quantities at risk.”

In a confusing chapter of the pandemic, experts share their own approaches The omicron variant has left many vaccinated people confused about how to stay safe. Four experts describe their personal behavior and risk calculus. NBC News

The rapid spread of the omicron variant has left many vaccinated people feeling confused about which activities are safe as the U.S. heads into the third year of the Covid-19 crisis.

Moderna CEO warns people may need fourth Covid shot as efficacy of boosters likely to decline over time

Moderna CEO Stephane Bancel on Thursday said the efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot in the fall to increase their protection.

Bancel said people who received their boosters last fall will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape the cold.

However, Bancel said the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses. The Moderna chief was interviewed by Goldman Sachs during the investment bank’s health-care CEO conference.

“I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not going to hold great,” Bancel said, referring to the strength of the booster shots.   ...